Rockwell Medical (RMTI) Shares Outstanding (2010 - 2026)
Rockwell Medical's (RMTI) quarterly Shares Outstanding (Entity) came in at $3.9 million in Q1 2026, up 15.22% YoY from $3.4 million in Q1 2025, and little changed on a QoQ basis from $3.9 million in Q4 2025.
Rockwell Medical (RMTI) Shares Outstanding (2010 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has 17 years of Shares Outstanding (Entity) data on file, last reported at $3.9 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 15.22% year-over-year to $3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.9 million (up 15.22% YoY) and the FY2025 annual result came in at $3.9 million, up 15.7% from the prior year.
- Shares Outstanding (Entity) was little changed at $3.9 million in Q1 2026, from $3.9 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $3.9 million in Q1 2026 to a low of $854422.0 in Q1 2022.
- A 5-year average of $2.6 million and a median of $3.0 million in 2024 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) advanced 0.41% — and 2023, when it jumped 155.45%.
- Tracing RMTI's Shares Outstanding (Entity) over 5 years: stood at $986684.0 in 2022, then soared by 136.38% to $2.3 million in 2023, then jumped by 46.02% to $3.4 million in 2024, then advanced by 15.7% to $3.9 million in 2025, then rose by 0.16% to $3.9 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $3.9 million (Q1 2026), $3.9 million (Q4 2025), and $3.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 832.44 Mn |
| 10 | Rockwell Medical | 29.93 Mn | 5.13 Mn | 3.24 Mn | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.94 Mn |
| Mar 31, 2026 | 3.94 Mn |
| Dec 31, 2025 | 3.60 Mn |
| Sep 30, 2025 | 3.60 Mn |
| Jun 30, 2025 | 3.43 Mn |
| Mar 31, 2025 | 3.41 Mn |
| Dec 31, 2024 | 3.11 Mn |
| Sep 30, 2024 | 3.16 Mn |
| Jun 30, 2024 | 3.05 Mn |
| Mar 31, 2024 | 2.93 Mn |
| Dec 31, 2023 | 2.33 Mn |
| Sep 30, 2023 | 2.75 Mn |
| Jun 30, 2023 | 1.85 Mn |
| Mar 31, 2023 | 1.84 Mn |
| Dec 31, 2022 | 986,684.00 |
| Sep 30, 2022 | 1.05 Mn |
| Jun 30, 2022 | 880,519.00 |
| Mar 31, 2022 | 854,422.00 |
| Dec 31, 2021 | 852,627.00 |
| Sep 30, 2021 | 853,483.00 |